Market News
Smart Trading. Simplified.
Stock Market Whiz Kid Works 1 Hour a Day. Makes Millions.
He was living with his parents. Two years later he had $5 million to play with - all because of this 1 EXTRA INCOME strategy.
To see how he did it click here.
Ternium Stock Forecast: Why Is It Up So Much?
Ternium Stock Forecast: Ternium S.A. is a manufacturer of high-quality steel products used in infrastructure and housing works. The company is Latin America’s leading steel producer, and operates production plants primarily in Mexico, Brazil, Argentina and the United States. Why Is Ternium Stock Up? Ternium has seen its share price steadily appreciate over the last […]
New "Trojan Horse" Treatment Could Cost $2 Million
The New York Times reports new treatment "will change medicine."
Wall Street thinks it could be a $2 TRILLION market worldwide.
And one small company owns the patent on it.
This unknown biotech's stock is set to surge 46,751% >>>
Is Restoration Hardware Stock A Buy?
Restoration Hardware Holdings Inc (NYSE:RH) is a Corte Madera, California-based home furnishing retailer. The company has a footprint of over 100 stores, and grew from the depths of its share price correction in 2020 by over 400 percent in the year thereafter. The push to work and school from home pushed a lot of people […]
A Rare Opportunity to Turn $1,000 into $461,800
On August 30, 2019, a small firm won a contract from the Pentagon to build a strange new weapon. The Joint Chiefs of Staff calls this new weapon "Unstoppable." This under-the-radar company is not yet a household name.
Our research proves that anyone who gets in now could turn $1,000 into $461,800 >>>
Michael Novogratz Bitcoin Prediction
Michael Novogratz Bitcoin Prediction: The most well-known names in finance have weighed in on the future of Bitcoin. ARK Invest’s Cathie Wood is convinced Bitcoin is poised to explode, and Tesla’s Elon Musk wholeheartedly agrees. On the other hand, traditionalists like the legendary Warren Buffett have referred to Bitcoin – and cryptocurrency as a whole […]
69% a year return. One type of stock. Really?
Why settle for puny 4% or 5% yields. My portfolio pays out a 69% cash on cash return. It's not magic. Or wishful thinking. I just buy one type of regular stock. No leverage, options, or gimmicks required.
9 Best Stocks Under $50 To Buy
Technology titans with high market capitalizations like Facebook [NASDAQ: FB] and Apple [NASDAQ: AAPL] attract the bulk of the attention from the financial media, but cheaper stocks offer up opportunities to profit big time too. In many respects, stocks under $50 represent a happy medium for investors. They’re often well known companies yet without the […]
Can 3 Words Make You $1.1 Million?
In October 2013, a scientist wrote 3 words on a piece of paper. They were simple words. A five-year-old could say them. But these words hold the key to a drug that Jim Cramer says could be "The Biggest Drug Ever."
Our research shows that anyone who gets in early could turn every $1,000 into $1.1 million >>>
Who Will Be the Next CEO of Amazon?
Amazon.com, Inc. (NASDAQ:AMZN) is one of the largest companies in the history of the world and one of few worth over $1 trillion. It was founded in 1994 by Jeff Bezos, who served as the company’s CEO for over 25 years before announcing in February 2021 that he’s stepping down. Despite being briefly unseated by […]
Small Biotech Could Soar 1,000%
There's no sector poised to deliver bigger gains in 2021 than small-cap biotech stocks.
In the past year alone...
Novavax Inc jumped from $6.26 to $270.51, a gain of 3,396%.
Aclaris Therapts jumped from $0.70 to $24.28 an increase of 1,583%.
Vaxart Inc rocketed from $0.97 to $14.94, a 1,083% jump.
Here's the next biotech we think could soar 1,000% >>>
View this email online if it doesn't display correctly. This newsletter is not financial advice. Please read our Disclaimer.
To unsubscribe from Financhill, click here.
PO Box 126
Catasauqua, PA 18032
Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.
The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.
The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The Financhill.com educational training program and software services are provided to improve financial understanding.
The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.
Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.
No comments:
Post a Comment